For example, serum‐based protein cancer biomarkers such as cancer antigen 125 (CA 125), carcinoem‐bryonic antigen (CEA), prostate‐specific antigen (PSA), and cancer antigen 19‐9 (CA 19‐9) are commonly used for monitoring lung cancer patients. This evidence concerns the gene CEACAM5 and lung carcinoma.